← All companies
TCRT
Alaunos Therapeutics, Inc.
$1.91
+0.03 +1.33%
Key statistics
from XBRL data in SEC filingsMarket cap
$46.5M
Revenue (TTM)
$3.00K
Net income (TTM)
-$4.11M
EPS (TTM)
$-2.12
P/E ratio
—
Dividend yield
—
Free cash flow
-$2.97M
Cash
$354K
Total assets
$1.88M
Gross margin
—
52-week range
$1.67 – $4.59
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 29, 2026
8-K
Other events
May 26, 2026
8-K
Other events
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 30, 2026
8-K
Delisting notice or listing-rule failure
Apr 15, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Other events
Mar 2, 2026
8-K
Terminated a material agreement; Modified rights of security holders; Other events
Jan 8, 2026
8-K
Other events
Dec 23, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Other events
Aug 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Director or officer change
Jul 22, 2025
8-K
Director or officer change
Jul 17, 2025
8-K
Modified rights of security holders; Shareholder vote results
Jul 10, 2025
8-K
Delisting notice or listing-rule failure; Director or officer change
Jul 2, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Jun 26, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws
Jun 26, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jun 10, 2025
8-K
Entered a material agreement; Unregistered sale of equity
May 23, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 30, 2025
8-K
Director or officer change
Apr 18, 2025
8-K
Director or officer change
Apr 15, 2025
8-K
Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws
Apr 14, 2025
8-K
Delisting notice or listing-rule failure; Other events
Apr 11, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Terminated a material agreement; Results of operations (earnings release)
Oct 10, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K/A
Modified rights of security holders; Amended charter or bylaws
Jul 17, 2024
8-K/A
Other events
Jul 17, 2024
8-K
Amended charter or bylaws
Jul 16, 2024
8-K
Other events
Jul 16, 2024
8-K
Changed accountants
Jun 21, 2024
8-K
Modified rights of security holders; Amended charter or bylaws; Shareholder vote results
Jun 12, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024
10-K
Fiscal year ended 2023-12-31
Apr 1, 2024
8-K
Director or officer change
Feb 22, 2024